What is the interpretation of a transferrin saturation of 63 %, serum iron of 143 µg/dL, total iron‑binding capacity of 226 µg/dL, and ferritin of 157 ng/mL, and what are the recommended next steps?

Interpretation: Biochemical Iron Overload Requiring Genetic Testing

Your iron studies demonstrate biochemical iron overload with a transferrin saturation of 63% (markedly elevated above the 45-50% threshold), warranting immediate HFE genetic testing for hereditary hemochromatosis. 1

Laboratory Analysis

Your results show:

• Transferrin saturation: 63% (critically elevated)
• Serum iron: 143 µg/dL (elevated)
• TIBC: 226 µg/dL (low-normal to low)
• Ferritin: 157 ng/mL (mildly elevated)

The transferrin saturation >50% is the most concerning finding and is characteristic of hemochromatosis, indicating disturbed plasma iron homeostasis from inappropriately low hepcidin concentration 1. This pattern—high transferrin saturation with moderately elevated ferritin—is the classic biochemical signature requiring genetic evaluation.

Immediate Next Steps

1. HFE Genetic Testing (Priority Action)

You meet criteria for genetic testing based on transferrin saturation >50% with elevated ferritin >150 ng/mL 1. The 2022 EASL guidelines specify 100% consensus that individuals with persistently elevated transferrin saturation should undergo HFE genotyping after informed consent 1.

Specifically test for:

• p.C282Y homozygosity (most common cause)
• p.C282Y/p.H63D compound heterozygosity
• Consider p.H63D in special clinical situations 1

2. Confirm Persistence of Abnormalities

Repeat iron studies (transferrin saturation and ferritin) fasting in the morning to confirm these are not transient elevations. Transferrin saturation can be affected by:

• Recent iron intake
• Inflammation (though your ferritin is not dramatically elevated, suggesting this is less likely)
• Alcohol consumption (alternative cause of elevated transferrin saturation) 1

3. Assess for Secondary Causes

Evaluate for conditions that can elevate iron parameters:

• Alcohol consumption history (major confounder—increases transferrin saturation and hepatocellular injury risk) 1
• Metabolic syndrome/fatty liver disease (can cause iron overload) 1
• Inflammatory conditions (though ferritin would typically be much higher)
• Liver enzyme abnormalities (AST, ALT)

Risk Stratification Based on Your Values

Your transferrin saturation of 63% places you at high risk for:

• True iron overload if genetic testing confirms hemochromatosis
• Progressive organ damage if untreated (liver fibrosis, cirrhosis, hepatocellular carcinoma, cardiomyopathy, diabetes, arthropathy)
• Serious infections from siderophilic pathogens like Vibrio vulnificus if consuming raw shellfish 1

However, your ferritin of 157 ng/mL is relatively modest, suggesting:

• Early-stage disease if hemochromatosis is confirmed
• Lower immediate risk of advanced fibrosis (ferritin <1,000 ng/mL has lower cirrhosis risk) 1

If Genetic Testing Confirms p.C282Y Homozygosity

Assessment for Organ Damage

With ferritin 157 ng/mL and normal liver enzymes (if present), you likely do not need:

• Liver biopsy (reserved for ferritin >1,000 ng/mL or elevated liver enzymes) 1
• MRI liver iron quantification (not required for diagnosis in p.C282Y homozygotes without additional risk factors, though it can predict phlebotomy burden) 1

Treatment Initiation

Phlebotomy therapy would be indicated with goals of:

• Induction phase: Target ferritin 50 ng/mL via 400-500 mL phlebotomy weekly or every 2 weeks 1
• Maintenance phase: Keep ferritin 50-100 ng/mL (or more relaxed targets of <200 ng/mL for women, <300 ng/mL for men in maintenance) 1
• Monitor hemoglobin before each session; reduce frequency if Hgb <12 g/dL, stop if <11 g/dL 1

Lifestyle Modifications

• Avoid iron supplementation and iron-fortified foods 1
• Avoid supplemental vitamin C (increases iron absorption) 1
• Limit red meat consumption 1
• Restrict alcohol (critical—increases fibrosis and cancer risk with iron overload) 1
• Avoid raw/undercooked shellfish and seawater wound exposure (risk of fatal Vibrio vulnificus sepsis with mortality >50%) 1

If Genetic Testing Shows Compound Heterozygosity or No HFE Mutations

With p.C282Y/p.H63D or p.H63D homozygosity:

• Investigate additional environmental risk factors (alcohol, metabolic syndrome) 1
• Management guided by phenotype, not genotype alone 1
• Iron overload is rare in p.H63D homozygotes (only 3.2% in studies) 1

If no HFE mutations are found:

• Consider MRI liver iron quantification to confirm true iron overload and assess distribution 1
• Evaluate for other causes: ferroportin disease, aceruloplasminemia, secondary iron overload 1

Critical Pitfalls to Avoid

1. Do not dismiss elevated transferrin saturation even if ferritin is only mildly elevated—transferrin saturation >50% is the key screening abnormality for hemochromatosis 1, 2
2. Do not delay genetic testing—your values exceed thresholds requiring evaluation
3. Do not assume inflammation explains your results—ferritin of 157 ng/mL is not high enough to suggest pure inflammatory hyperferritinemia
4. Do not start empiric phlebotomy before genetic confirmation unless clinical urgency exists

Family Screening

If p.C282Y homozygosity is confirmed, all first-degree adult relatives should undergo HFE genetic testing (100% consensus recommendation) 1.